Topic: FDA Rx Approval Process disaster - Nuplazid
Keebler
Honored Contributor (25K+ posts)
Member # 12673
posted
- Not just about the disaster of Pimavanserin / Nuplazid -- also about the FDA Approval Process, Dampening of Concerns, the cause of so much more misery for some patients and their families . . .
and, of course from where we're sitting, knowing that at least some of these patients might have / had as the cause of Parkinson's a tick-borne infection that went / goes undiagnosed.
It has happened, for some, to have been diagnosed with Parkinson's (or ASL, or MS) when lyme / TBD were the root issues. Some have seen proper diagnosis and treatment for lyme / TBD cause the other neurological misdiagnoses to fade away.
Few reading this article will also know of that compounding error / damage / lost chance, though.
Yet this article is about how disregarding due diligence & squashing concerns has caused so much damage. And, if the FDA does this with one drug, what about the others?
FDA worried drug was risky; now reports of deaths spark concern
By Blake Ellis and Melanie Hicken, CNN Investigates - April 9, 2018 -
Posts: 48021 | From Tree House | Registered: Jul 2007
| IP: Logged |
Keebler
Honored Contributor (25K+ posts)
Member # 12673
posted
- I don't have the energy or a proper command to write concisely. Yet if anyone here feels they can reach out and share lyme / TBD possible misdiagnoses with this team, please do so.
Following the CNN report in post above is this note:
Do you have information to share about Nuplazid or other drugs targeting the elderly?
The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:
The
Lyme Disease Network of New Jersey 907 Pebble Creek Court,
Pennington,
NJ08534USA http://www.lymenet.org/
UBBFriend: Email this page to someone!
Printer-friendly view of this topic